Chapter 5 · Introduction

Chapter 5 — Valuing a Company

What is a share really worth? Forecast a company's free cash flow, discount it at a rate set by its risk, sum the growing tail as a geometric series — then read the market's ratios as shorthand for the same calculation and test how fragile every answer is.

Every day the market puts a price on thousands of companies, and every day someone asks whether the price is right. A research note says a share "should" be worth ₹248; a screener shows that one company trades at 45 times its profit and another at 18; a television guest calls a bank "cheap because it trades below book value". Behind all of these claims is one idea you already know from Chapter 1: a rupee in the future is worth less than a rupee today, so an asset is worth the present value of the cash it will pay. A company is simply an asset whose cash flows are uncertain, grow over time and, in principle, never end. Valuing it means forecasting those cash flows, choosing a discount rate that reflects their risk — the cost of equity from CAPM in Chapter 4 — and adding up an infinite stream. The infinite part is a geometric series, and its sum $C_1/(k-g)$, the Gordon growth formula, is the single most important formula in equity valuation.

The second half of the chapter turns to the numbers investors actually quote: EPS, P/E, PEG, P/B, EV/EBITDA, dividend yield and ROE. Each looks like a quick rule of thumb, but each is a compressed DCF — a P/E is $\text{payout}/(k-g)$, a P/B is $(\text{ROE}-g)/(k-g)$ — and the algebra shows when a high multiple is earned and when a low one is a trap. The DuPont identity splits ROE into margin, turnover and leverage; relative valuation compares a company with its peers; and sensitivity and scenario tables show what has to be true for a price to make sense. Calculus enters naturally: the derivative of the Gordon value shows why valuations are so sensitive when growth is close to the discount rate, and why careful investors insist on a margin of safety. Every company in this chapter is hypothetical and every input illustrative; the aim is to understand valuations, not to pick shares.

Free cash flow→Cost of equity & WACC→Growing perpetuity→Terminal value & DCF per share→Dividend discount models→Sensitivity & margin of safety→EPS, P/E, PEG→P/B, EV/EBITDA→ROE & DuPont→Peers & scenarios
🎯 By the end of this chapter you can…
  • compute free cash flow to the firm and to equity from a company's income statement and balance-sheet changes, and explain why profit is not cash;
  • estimate a cost of equity with CAPM and a WACC with market-value weights, and match each cash flow to its discount rate;
  • derive the growing-perpetuity formula as a geometric series and use it as a terminal value in a DCF that ends in a value per share;
  • value a share with the Gordon and two-stage dividend discount models, find the return and growth a market price implies, and use the sustainable growth rate $g=b\times\text{ROE}$;
  • measure a valuation's sensitivity with derivatives and sensitivity tables, and state a margin of safety honestly;
  • compute and interpret EPS, P/E, PEG, P/B, EV/EBITDA and dividend yield, and derive the justified P/E and P/B from the Gordon model;
  • decompose ROE with DuPont, value a company against its peers, build scenario tables by splitting a return into earnings growth and the change in the multiple, and explain why cheap can stay cheap.
Teaser — How Far into the Future Does a Company's Value Lie?

A hypothetical business pays ₹100 next year, growing at rate $g$ for ever, discounted at rate $k$. Each blue bar is one year's share of the total present value; the green curve is the running total. Press Play to add the years one by one, then change $g$ and $k$: the closer $g$ gets to $k$, the further into the future the value moves. (Illustrative inputs.)

11.0%5.0%60
total value C₁/(k − g)—
from years 1–10—
from years 11–30—
after year 30—
half the value arrives by—

Where this shows up in real life

You meet this chapter whenever you read a brokerage research report with a "target price", an IPO prospectus that compares the issue price with listed peers' P/E and EV/EBITDA, a mutual-fund factsheet reporting the portfolio's average P/E and P/B, or a news story about a company "trading below book". Equity research analysts, fund managers, investment bankers pricing IPOs and acquisitions, credit analysts, independent valuers who value unlisted shares, and companies deciding whether to buy back shares all run DCFs, dividend models, peer tables and sensitivity grids — the same calculations you will do here on hypothetical companies. Certification examinations for research analysts and investment advisers ask about EPS, P/E, DCF and the dividend discount model, and finance interviews love "walk me through a DCF" and "why can a low-P/E stock be a bad investment?". The ideas connect backwards to present value and NPV (Chapter 1) and CAPM (Chapter 4), and forwards to the dividend adjustments in futures and option pricing (Chapter 6) and to judging "guaranteed return" claims (Chapter 8).

Sections in this chapter

✅ Before you start

You need present value and discounting (§1.1), the geometric series and the perpetuity $C/i$ (§1.2), and NPV and IRR (§1.3) — a DCF is an NPV whose "project" is a whole company. Market capitalisation, dividends and bonus issues come from §2.1, and the G-sec yield used as the risk-free rate from §2.3. Beta (§3.2) and CAPM (§4.2) give the cost of equity; if you have not met CAPM yet, the one formula you need is $k_e=r_f+\beta\,(E[r_m]-r_f)$. From calculus you need only the derivative of $1/x$; no accounting background is assumed — every statement item is explained when it first appears.